BDRX
Biodexa Pharmaceuticals Plc
There isn't enough reported data to score BDRX yet.
BDRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
BDRX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BDRX PE Valuation
BDRX has no meaningful PE right now: it lost money over the past year.
BDRX Forward outlook
There aren't enough analyst estimates for BDRX to show an outlook.
BDRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2021 | -$1,442,747.93 | +$9,581,150.65 |
BDRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2021 | $768.9K | +69% |
| Q4 2020 | $456.3K | -49% |
| Q4 2019 | $896.6K | -65% |
| Q4 2018 | $2.6M | -74% |
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -807% | -198 points |
| Q4 2021 | -1211% | -979 points |
| Q4 2020 | -6717% | N/A |
| Q4 2019 | -1679% | N/A |
| Q4 2018 | -610% | N/A |
| Q4 2017 | -231% | N/A |
BDRX's operating margin was −807% last quarter, down 198 points from the same quarter a year ago.
BDRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2021 | -$8.4M | +$4.2M |
| Q4 2020 | -$12.7M | -$3.6M |
| Q4 2019 | -$9M | +$9.2M |
| Q4 2018 | -$18.2M | -$45.2K |
BDRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +1 shares |
BDRX Net Leverage
BDRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BDRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.5 | Oversold |
| Stochastic | 3.1 | Oversold |
BDRX's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).
BDRX PE vs Healthcare Sector
BDRX has no meaningful PE right now: it lost money over the past year.
BDRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.67 | 35% below |
| 20 week MA | $8.91 | 73% below |
| 50 week MA | $38.4 | 94% below |
| 100 week MA | $361.1 | 99% below |
| 200 week MA | $104,690.8 | 100% below |
BDRX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
BDRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52,000,000.0 | $28,800,000.0 | -45% |
| 2021 | $28,800,000.0 | $20,000,000.0 | -31% |
| 2022 | $20,000,000.0 | $2,304,320.0 | -88% |
| 2023 | $2,304,320.0 | $26,800.0 | -99% |
| 2024 | $26,800.0 | $1,716.0 | -94% |
| 2025 | $1,716.0 | $105.2 | -94% |
| 2026 YTD | $105.2 | $2.38 | -98% |
BDRX has finished every year since 2020 lower, and it's down 98% so far in 2026.